A multidisciplinary panel of experts provides an overview of the economic burden of HIV and the role of pre-exposure prophylaxis (PrEP) in preventing HIV transmission. Ian Frank, MD and Jeffrey ...
HIV pre-exposure prophylaxis (PrEP) is a prevention strategy which includes the regular or event-driven use of antiretroviral medication to prevent HIV infection in adults. Several clinical trials ...
A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...
HIV spreads in the human body by targeting and infecting T cells, the critical white blood cells of our immune system. PrEP works by blocking HIV from replicating inside T cells after exposure, ...
Post-exposure prophylaxis-in-pocket (PIP) was associated with healthcare savings and improved quality of life outcomes compared to pre-exposure prophylaxis (PrEP), based on data presented at ...
Health and Me on MSN
Years after PrEP rollout, the HIV prevention drug still remains a privilege in India
India introduced PrEP guidelines in 2022, but access remains limited due to lack of public rollout, low awareness, and high costs. Meanwhile, HIV prevalence has declined overall but remains ...
Pre-exposure prophylaxis (PrEP) is a medication regimen that is used to protect at-risk populations from HIV infection. The FDA approved the drug TRUVADA ...
MONTRÉAL, March 25, 2025 /CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (PFE) and Shionogi as shareholders, is pleased to ...
The inaugural direct-to-consumer campaign for the injectable drug debuted earlier this year, centering around a TV ad featuring a remake of Ciara and Missy Elliott’s 2004 hit song “1, 2 Step”—now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results